Navigation Links
ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)
Date:11/10/2010

e in a class by itself.  We think that this new agent has extraordinary potential in treating previously intractable conditions such as the devastating vasculitis seen in autoimmune diseases."

CCX168 Study Results and ANCA-Associated Vasculitis

In Phase I clinical trials CCX168 was safe and well tolerated, with excellent oral bioavailability and dose-proportional exposure increases in human subjects.  Pharmacokinetic and pharmacodynamic data indicated that 30 to 50 mg of CCX168 given orally twice daily in humans results in greater than 90% C5aR coverage in blood at all times, and this is considered optimal for CCX168 evaluation in Phase II trials in vasculitis.

Supporting the Phase I data are results from a mouse model of anti-neutrophil cytoplasmic autoantibody (ANCA) associated glomerulonephritis (GN).  In this study, human C5aR transgenic mice were employed, and ANCA kidney disease was profoundly inhibited by doses of CCX168 that are very similar to those achieved safely in the human Phase I studies.

CCX168 is a highly potent and very selective compound that specifically targets the receptor for the anaphylotoxin designated C5a, a component of the body's complement system and a potent driver of the inflammatory response associated with ANCA-associated vasculitis and other autoimmune disease. In ANCA disease, auto-antibodies lead to the activation and increased adhesiveness of neutrophils to endothelial cells that line the interior surfaces of blood vessels in the kidney and other organs.  These adhering neutrophils accumulate inside the blood vessels and initiate an inflammatory cascade.  Activation of the complement pathway occurs as a consequence, with production of C5a, one of the most potent pro-inflammatory mediators of the complement system.  C5a, through binding to its receptor C5aR, induces expression of additional adhesion molecules and chemotactic factors, thus
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
2. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
3. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
4. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
5. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
6. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
7. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
8. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
9. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
10. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 The Board of ... (AMCP) last evening expressed support for the "Pharmacists, ... Commission of Pharmacy Practitioners (JCPP).  As a JCPP ... a two-year period to develop a scalable, viable ... "Pharmacists are fast becoming one of ...
(Date:7/30/2014)... and Markets has announced the addition of the "Hematology ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 The ... in developed countries; however, it is expected to witness high growth ... India , and Brazil in ... analyzers and reagents market is driven by factors such as increasing ...
(Date:7/30/2014)... , July 30, 2014 /PRNewswire-iReach/ -- Transluminal Technologies ... medical device company, has announced today that they ... CD™ Vascular Closure Device. Velox CD™ provides a ... following percutaneous femoral procedures. The single size velox ... in size from 5F to 8F.  ...
Breaking Medicine Technology:AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2Hematology Analyzers & Reagents Market - Forecasts to 2019 2Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2
... July 29 IRIDEX Corporation (Nasdaq: IRIX ) today ... Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use ... devices already in the IRIDEX product line, collectively identified and sold as ... , , ...
... For All® Inc., MMM Healthcare, Inc. (MMM) and ... access to medications, lab testing and medical imaging at substantial rate reductions ... , , ... that entitles users to savings that range as high as 50 to ...
Cached Medicine Technology:IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery 2IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery 3Free For All® Inc., MMM and PMC Assist Members with Pharmacy Discount 2Free For All® Inc., MMM and PMC Assist Members with Pharmacy Discount 3Free For All® Inc., MMM and PMC Assist Members with Pharmacy Discount 4
(Date:7/30/2014)... 2014 Good Neighbor Community Services ... upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , In this segment, ... Services’ vision to redefine the traditional approach to ... services. Through passion, innovation, determination, excellence, and collaboration, ...
(Date:7/30/2014)... SF Cable, distributor of the highest quality cables, ... internet with guaranteed customer satisfaction announces the availability of ... These lightning cords are MFI certified to meet Apple ... Cable Lightning to USB Cables feature the ... and syncing. Compatible with the iPhone 5S/5C/5 plus iPad ...
(Date:7/30/2014)... IN (PRWEB) July 30, 2014 ... the opening of its new Carmel office on July ... staff will finally be moving to the state-of-the-art suite, ... cozy and innovative space will allow for one-on-one patient ... cosmetic surgery experience. , Dr. Hamilton’s new office-suite ...
(Date:7/30/2014)... ... ... ... , UCLA researchers interviewed people with diverticulitis and confirmed that many suffer psychological and physical symptoms long after ... a UCLA team led by Dr. Brennan Spiegel interviewed patients in great detail about the symptoms they experience weeks, months or even ...
(Date:7/30/2014)... 2014 As the controversy surrounding the ... surgeries continues to grow, Bernstein Liebhard LLP notes that ... for a ban on uterine morcellation. According to a ... with leiomyosarcoma following a hysterectomy that involved the use ... diagnosis, the aggressive cancer had progressed to Stage 4. ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:SF Cable Delivers Certified Lightning Cable in Multiple Sizes and Colors 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4
... Practice Guidelines (CPG) has recommended that waist circumference be ... that a national surveillance system be developed that incorporates ... ,This represents a landmark publication, as Canada is the ... guidelines to address the management and prevention of overweight ...
... body to address issues such as food quality and safety, ... ,"We have been concerned with integration of our food ... agencies, and hence we have recently enacted the Food Safety ... be administered by a single autonomous and scientific regulatory body," ...
... a heat wave with day temperatures in state capital ... shooting// up to 42 degrees Celsius. ,Roads ... Korba. In Raipur, people preferred to remain indoors while ... department has forecast a further rise in heat this ...
... agreed to lower the prices of Kaletra/Aluvia in low ... on a request from the World Health Organization’s Director-General ... the treatment of HIV-1 infected adults and children above ... antiretroviral agents. It is in a category of HIV ...
... obviously stressed. Who wouldn’t be with a daughter like Tracey! ... puffing her way through// a mountain of cigarettes three or ... Hunt, formerly Langton and Rachid) is a long-running character on ... by Anne Kirkbride since 1972. Deirdre has become synonymous with ...
... the Novartis case, the government of India is moving fast ... ,It has now been notified that all patent litigations filed ... amended Patent Act have been transferred to the Intellectual Property ... pharmaceutical companies have filed cases in High Courts and lower ...
Cached Medicine News:Health News:New Guidelines to Address Growing Obesity Epidemic 2Health News:New Guidelines to Address Growing Obesity Epidemic 3Health News:Abbott to Subsidize Price of HIV Drug 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 3Health News:Patents: Appellate Board Becomes Functional 2
... a fully automated clinical chemistry analyzer. ... assay test parameters with a view ... 60 is an integrated system for ... special chemistries including specific proteins, TDM, ...
... Slide Rack works hand in hand with ... organized, reliable method for immunostaining. The Sequenza ... which ensures consistency and excellent staining quality. ... runs (up to 50 slides/run) with a ...
Inquire...
ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings....
Medicine Products: